DiBardino D J
Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Tex Heart Inst J. 1999;26(3):198-205.
The history of heart surgery, spanning only 100 years to date, has seen some of the most daring and persistent men and women in all of medical history. Many aspects of heart surgery, including such innovations as the heart-lung machine, aortic aneurysm surgery, and the correction of congenital heart defects, have provided future surgeons with an important lesson: diligent research can solve complex problems. The history and development of cardiac transplantation is particularly full of challenges that have been overcome, with the research phase alone spanning more than 90 years. During that time, essential contributions came from all over the world, including the United States, Russia, England, and South Africa. As is typical of medical advancement, individual contributions did not stand alone but added to the experience of those who had come before. Even so, the work of a few particular groups deserves special recognition. Most notable is the Stanford team, led by Dr. Norman Shumway, who continued to transplant human hearts when other institutions had abandoned hopes for the operation. Largely because of the commitment of that team, cardiac transplantation has become a standard option in the treatment of end-stage heart disease. Currently, only the availability of donor hearts limits the number of cardiac transplantations performed worldwide.
心脏外科的历史至今仅有100年,却见证了医学史上一些最勇敢执着的人。心脏外科的许多方面,包括心肺机、主动脉瘤手术和先天性心脏缺陷矫正等创新,都给未来的外科医生上了重要的一课:勤奋研究能够解决复杂问题。心脏移植的历史与发展尤其充满了被克服的挑战,仅研究阶段就跨越了90多年。在此期间,来自世界各地的重要贡献者包括美国、俄罗斯、英国和南非。正如医学进步的典型情况一样,个人贡献并非孤立存在,而是融入了前人的经验之中。即便如此,有几个特定团队的工作值得特别认可。最值得注意的是由诺曼·舒姆韦博士领导的斯坦福团队,当其他机构放弃心脏移植手术的希望时,该团队仍继续进行人体心脏移植。很大程度上由于该团队的奉献精神,心脏移植已成为治疗终末期心脏病的标准选择。目前,全球心脏移植手术的数量仅受供体心脏可用性的限制。